20251219 124935 uses. The change is expected to make it easier for scientists to conduct medical research into cannabis, including its benefits, risks, and other potential treatments. The reclassification also allows for a pilot program that will reimburse Medicare patients for products containing CBD, a cannabis-derived compound that does not produce a high and is already widely used, while the other areas eases some regulatory barriers. It does not legalize recreational marijuana at the federal level and does not change how law enforcement handles marijuana-related arrests. Officials say the shift must still go through a formal rulemaking process before it fully takes effect. The move reflects growing acceptance of marijuana's medical value in the United States even as
